Treatment of Acute Nephrotic Syndrome
For children with acute nephrotic syndrome, initiate oral glucocorticoids (prednisone or prednisolone) for either 8 weeks (4 weeks daily followed by 4 weeks alternate-day) or 12 weeks (6 weeks daily followed by 6 weeks alternate-day), combined with supportive measures including sodium restriction, loop diuretics, and ACE inhibitors or ARBs. 1
Initial Treatment Approach
The cornerstone of acute nephrotic syndrome treatment is oral glucocorticoid therapy, as recommended by the most recent KDIGO 2025 guidelines 1. This represents the highest quality evidence available and should guide your initial management strategy.
Glucocorticoid Regimen
You have two evidence-based options for initial treatment:
- 8-week regimen: 4 weeks of daily glucocorticoids followed by 4 weeks of alternate-day dosing
- 12-week regimen: 6 weeks of daily glucocorticoids followed by 6 weeks of alternate-day dosing
Both regimens carry a 1B recommendation strength, meaning you can choose either based on individual patient factors such as age, weight, and risk of glucocorticoid toxicity 1.
Essential Supportive Measures
While glucocorticoids address the underlying pathophysiology, supportive therapy is critical for managing complications and improving quality of life:
Fluid and Electrolyte Management:
- Sodium restriction (typically 1-2 g/day)
- Fluid restriction if significant edema present
- Loop diuretics (furosemide) for volume overload 2, 3
Antiproteinuric Therapy:
Lipid Management:
- Statins to normalize serum lipid concentrations, particularly important given the hyperlipidemia associated with nephrotic syndrome 2
Important Clinical Considerations
Complications to Monitor
Patients with acute nephrotic syndrome face several serious complications that require vigilant monitoring:
- Thromboembolism: Deep vein thrombosis, renal vein thrombosis, and pulmonary emboli are significant risks 2, 3
- Infections: Increased susceptibility due to immunoglobulin loss and immunosuppression 3, 4
- Acute kidney injury: Can occur from the underlying disease process 3
When to Escalate Treatment
If the patient develops steroid-resistant nephrotic syndrome (failure to achieve remission after 4-6 weeks of glucocorticoid therapy), second-line therapy with cyclosporine or tacrolimus is recommended 1. This represents a critical decision point that significantly impacts long-term outcomes.
For frequently relapsing or steroid-dependent cases, glucocorticoid-sparing agents should be introduced to prevent relapses and minimize toxicity. The KDIGO 2025 guidelines no longer distinguish between first-line and alternative agents, but suggest:
- Frequently relapsing NS: Oral cyclophosphamide or levamisole may be preferable
- Steroid-dependent NS: Mycophenolate mofetil, rituximab, calcineurin inhibitors, or cyclophosphamide 1
Critical Pitfall to Avoid
Do not routinely give daily glucocorticoids during upper respiratory tract infections in children with frequently relapsing or steroid-dependent nephrotic syndrome, as recent evidence (PREDNOS2 study) shows no benefit in preventing infection-associated relapses 1. This represents an important update from previous practice patterns.
Special Populations
Adults vs. Children
While the evidence provided focuses primarily on pediatric nephrotic syndrome, adult management follows similar principles with supportive care (sodium restriction, diuretics, ACE inhibitors/ARBs, statins) being universally applicable 3. However, the underlying histologic subtypes differ, with membranous nephropathy and focal segmental glomerulosclerosis being more common in adults 3.
Secondary Causes
Before initiating immunosuppressive therapy, rule out secondary causes including diabetes mellitus, systemic lupus erythematosus, medications, infections, and malignancies 5, 3. This is essential as treatment strategies differ significantly for secondary nephrotic syndrome.
Monitoring Strategy
Inpatient monitoring is required for patients with:
- Significant edema
- Severe hypertension (stage 2)
- Acute kidney injury 6
Long-term follow-up should include:
- Urinalysis for proteinuria monitoring (home monitoring can be taught to families)
- Serum creatinine
- Blood pressure monitoring
- Assessment for medication adverse effects 7